The concept of innovation is broad and its implications are diverse. But what is medical innovation and what are its developments? We will talk about this during our sessions of A Coffee for Rheumatology.
North America, followed by Europe and Southeast Asia, occupy the top three places in innovation according to the 2019 Global Innovation Index (Global Innovation Index GII), conducted by the World Intellectual Property Organization. Latin America ranks fifth out of seven in the regional ranking. In addition, Switzerland is the most innovative country in the world, followed by Sweden, the United States of America, the Netherlands and the United Kingdom, followed by India, South Africa, Israel and Singapore. Chile is the first country in the region to appear on the list in 51st position out of 129 economies analyzed.
The global innovation landscape is changing, as is innovation in the healthcare sector. There are many terms, scopes and even investments.
In view of all this, the questions arise: what is medical innovation? how are we developing these innovation processes in rheumatology? what strategies do scientific societies use to promote innovation?
Dr. Diego Jaimes along with Carlo Vinicio Caballero, editor in chief of Global Rheumatology, will talk with Cesar Graf, technological pioneer and innovator in health, rheumatologist and current president of the Argentine Society of Rheumatology, and Rafael Grossman, surgeon based in Maine (USA), educator and futurist in Health around these issues in "A coffee for rheumatology".
